555 related articles for article (PubMed ID: 28501028)
1. Multicentric Castleman disease of hyaline vascular variant presenting with unusual systemic manifestations: a case report.
Basnayake BMDB; Wazil AWM; Kannangara T; Ratnatunga NVI; Hewamana S; Ameer AM
J Med Case Rep; 2017 May; 11(1):135. PubMed ID: 28501028
[TBL] [Abstract][Full Text] [Related]
2. [Hyaline-vascular Multicentric Castleman's Disease in an immunocompetent patient].
Zapata-Bonilla SA; López Vargas R; Scherling-Ocampo AA; Morales Leyte AL; García Ilizaliturri L
Gac Med Mex; 2015; 151(5):648-54. PubMed ID: 26526479
[TBL] [Abstract][Full Text] [Related]
3. Idiopathic Multicentric Hyaline Vascular-Type Castleman Disease.
Moutinho A; Cunha RG; Jamal SK; Lisboa MM; Tavares S
Case Rep Hematol; 2021; 2021():6620666. PubMed ID: 33936820
[TBL] [Abstract][Full Text] [Related]
4. Castleman disease presenting with jaundice: a case with the multicentric hyaline vascular variant.
Park JB; Hwang JH; Kim H; Choe HS; Kim YK; Kim HB; Bang SM
Korean J Intern Med; 2007 Jun; 22(2):113-7. PubMed ID: 17616028
[TBL] [Abstract][Full Text] [Related]
5. Unicentric Castleman disease, hyaline vascular variant, stromal rich, with increased plasma cells and a high level of serum IL-6: Raising the diagnostic and therapeutic issues.
Lyapichev KA; Sukswai N; Strati P; Iyer SP; Medeiros LJ; Miranda RN
Ann Diagn Pathol; 2019 Dec; 43():151398. PubMed ID: 31630065
[No Abstract] [Full Text] [Related]
6. Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease.
Lurain K; Yarchoan R; Uldrick TS
Hematol Oncol Clin North Am; 2018 Feb; 32(1):75-88. PubMed ID: 29157621
[TBL] [Abstract][Full Text] [Related]
7. Treatment of unicentric Castleman disease with neoadjuvant rituximab.
Bandera B; Ainsworth C; Shikle J; Rupard E; Roach M
Chest; 2010 Nov; 138(5):1239-41. PubMed ID: 21051400
[TBL] [Abstract][Full Text] [Related]
8. Hyaline vascular variant of unicentric Castleman disease of the tonsil: a case report.
Li P; Liu H; Li H; Li A; Yu G; Yin W
Diagn Pathol; 2019 Jun; 14(1):70. PubMed ID: 31253137
[TBL] [Abstract][Full Text] [Related]
9. Brief communication: rituximab in HIV-associated multicentric Castleman disease.
Bower M; Powles T; Williams S; Davis TN; Atkins M; Montoto S; Orkin C; Webb A; Fisher M; Nelson M; Gazzard B; Stebbing J; Kelleher P
Ann Intern Med; 2007 Dec; 147(12):836-9. PubMed ID: 18087054
[TBL] [Abstract][Full Text] [Related]
10. Coexistence of disseminated Kaposi sarcoma and multicentric Castleman disease in an HIV-infected patient under viral suppression.
Lin IF; Lin JN; Tsai TH; Hsu CT; Wu YY; Lai CH
Int J STD AIDS; 2021 Mar; 32(3):286-289. PubMed ID: 33555231
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous involvement as initial presentation of multicentric plasmacytic Castleman disease.
Chen H; Ba W; Chen H; Yang H
J Cutan Pathol; 2021 May; 48(5):701-705. PubMed ID: 33469928
[TBL] [Abstract][Full Text] [Related]
12. Human Herpesvirus Type 8-positive Multicentric Castleman Disease.
Melikyan AL; Egorova EK; Julhakyan HL; Kovrigina AL; Savchenko VG
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S159-65. PubMed ID: 27133959
[TBL] [Abstract][Full Text] [Related]
13. Arteriolar hyalinosis and arterial hypertension as possible surrogate markers of reduced interstitial blood flow and hypoxia in glomerulonephritis.
Bazzi C; Stivali G; Rachele G; Rizza V; Casellato D; Nangaku M
Nephrology (Carlton); 2015 Jan; 20(1):11-7. PubMed ID: 25230383
[TBL] [Abstract][Full Text] [Related]
14. Human herpesvirus 8-associated multicentric Castleman disease in a patient with advanced HIV infection: A case report.
Guayboon T; Chinthammitr Y; Sukpanichnant S; Horthongkham N; Angkasekwinai N
Medicine (Baltimore); 2021 Dec; 100(49):e28077. PubMed ID: 34889256
[TBL] [Abstract][Full Text] [Related]
15. A Rare Lymphoproliferative Disease: Castleman Disease.
Gündüz E; Özdemir N; Bakanay ŞM; Karakuş S
Turk J Haematol; 2021 Dec; 38(4):314-320. PubMed ID: 34719151
[TBL] [Abstract][Full Text] [Related]
16. [PET-CT documented remission of multicentric Castleman disease after treatment with rituximab: case report and review].
Adam Z; Szturz P; Koukalová R; Řehák Z; Pour L; Krejčí M; Šmardová L; Eid M; Volfová P; Čermáková Z; Křen L; Sokol F; Hanke I; Michalková E; Král Z; Mayer J
Vnitr Lek; 2015 Mar; 61(3):251-9. PubMed ID: 25873122
[TBL] [Abstract][Full Text] [Related]
17. Multicentric Plasma-Cell Type Castleman Disease Masquerading As Hodgkin Lymphoma: A Case Report.
Ekwere TA; Eziagu UB
J Lab Physicians; 2020 Dec; 12(3):225-229. PubMed ID: 33268942
[TBL] [Abstract][Full Text] [Related]
18. HHV-8-negative multicentric Castleman disease presenting as a crescentic immune complexes membranoproliferative glomerulonephritis.
Nunes MB; Rotman S; Duss FR; Halfon M
BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31911409
[TBL] [Abstract][Full Text] [Related]
19. Multifocal Castleman disease in pediatrics: case report.
Baserga M; Rosin M; Schoen M; Young G
J Pediatr Hematol Oncol; 2005 Dec; 27(12):666-9. PubMed ID: 16344673
[TBL] [Abstract][Full Text] [Related]
20. EBV+ HHV-8+ Multicentric Castleman Disease With Plasmablastic Aggregates in an HIV+ Man: An Evolving Clinicopathologic Entity.
Shivane A; Pearce A; Khatib N; Smith MEF
Int J Surg Pathol; 2018 Jun; 26(4):338-341. PubMed ID: 29198143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
